Haemalogix Company
Haemalogix focuses on the development and commercialization of novel immuno-oncology and immune-therapies.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
Sydney, New South Wales, Australia
Estimated Revenue:
$1M to $10M
Register and Claim Ownership